Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Escalade (ESCA) Cash & Equivalents (2016 - 2025)

Escalade (ESCA) has disclosed Cash & Equivalents for 16 consecutive years, with $11.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 183.21% to $11.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, up 183.21% year-over-year, with the annual reading at $11.9 million for FY2025, 183.21% up from the prior year.
  • Cash & Equivalents hit $11.9 million in Q4 2025 for Escalade, up from $3.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $11.9 million in Q4 2025 to a low of $16000.0 in Q4 2023.
  • Historically, Cash & Equivalents has averaged $4.4 million across 5 years, with a median of $4.1 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: plummeted 99.6% in 2023 and later skyrocketed 26112.5% in 2024.
  • Year by year, Cash & Equivalents stood at $4.4 million in 2021, then decreased by 9.3% to $4.0 million in 2022, then tumbled by 99.6% to $16000.0 in 2023, then surged by 26112.5% to $4.2 million in 2024, then surged by 183.21% to $11.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for ESCA at $11.9 million in Q4 2025, $3.5 million in Q3 2025, and $10.4 million in Q2 2025.